Treatment of Tongue Lymphangioma with Intralesional Combination Injection of Steroid, Bleomycin and Bevacizumab
Archives of Craniofacial Surgery
; : 54-58, 2017.
Article
en En
| WPRIM
| ID: wpr-199173
Biblioteca responsable:
WPRO
ABSTRACT
Lymphangioma is a congenital malformed lymphatic tumor that rarely involves the tongue. In our clinic, a 10-year-old female presented with lymphangioma circumscriptum involving the right two-thirds of the tongue. We administered an intralesional combination injection of triamcinolone, bleomycin, and bevacizumab as a treatment. Almost complete remission after combination therapy was achieved without complications such as edema, swallowing difficulties or recurrence. Bevacizumab, an inhibitor of vascular endothelial growth factor, was effective for the treatment of lymphangioma of the tongue in this case. No recurrence was noted at the 1-year follow up.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Recurrencia
/
Lengua
/
Bleomicina
/
Triamcinolona
/
Estudios de Seguimiento
/
Deglución
/
Factor A de Crecimiento Endotelial Vascular
/
Edema
/
Bevacizumab
/
Linfangioma
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Child
/
Female
/
Humans
Idioma:
En
Revista:
Archives of Craniofacial Surgery
Año:
2017
Tipo del documento:
Article